Brendan Frett
Affiliations: | University of Arkansas for Medical Sciences, United States |
Google:
"Brendan Frett"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang L, Moccia M, Briggs DC, et al. (2022) Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose. Journal of Medicinal Chemistry. 65: 1536-1551 |
| Zhang L, Lakkaniga NR, Bharate JB, et al. (2021) Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor. European Journal of Medicinal Chemistry. 225: 113776 |
| Kharbanda A, Tran P, Zhang L, et al. (2021) Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncology. European Journal of Medicinal Chemistry. 225: 113763 |
| Saha D, Ryan KR, Lakkaniga NR, et al. (2021) Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development. Journal of Medicinal Chemistry |
| Moccia M, Yang D, Lakkaniga NR, et al. (2021) Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases. Scientific Reports. 11: 16103 |
| Kharbanda A, Zhang L, Saha D, et al. (2021) Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors. European Journal of Medicinal Chemistry. 223: 113660 |
| Yan W, Zhang L, Lv F, et al. (2021) Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 216: 113265 |
| Frett B, Saha D, Ryan KR, et al. (2021) Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered via a Fragment Optimization Approach. Chemmedchem |
| Wang J, Cheng P, Pavlyukov MS, et al. (2020) Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. The Journal of Clinical Investigation |
| Wang J, Cheng P, Pavlyukov MS, et al. (2020) Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. The Journal of Clinical Investigation. 130: 5027 |